Alzheimer’s disease could be slowed by boosting a certain protein in the brain, researchers say
Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...
Study finds Alzheimer's drugs might boost healthy protein in brain
Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.
SCNow1d
CareSouth patient one of the first in nation to receive Alzheimer's infusion
A CareSouth Carolina patient is among the first in the United States to receive a groundbreaking treatment aimed at slowing ...
Alzheimer’s heterogeneity necessitates diverse enrollment in clinical trials
Clinical trials need to evolve screening criteria to include diverse patient groups as more Alzheimer's disease drugs become ...
HealthDay on MSN5d
Alzheimer's Drugs May Work in Whole New Way, Study Finds
Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been ...
McKnight's Long-Term Care News5d
Study shows Alzheimer’s drugs may boost protein, not just lower amyloid
Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, ...
Yahoo5d
Study finds Alzheimer's drugs might boost healthy protein in brain
Two monoclonal antibody treatments to slow Alzheimer's disease, lecanemab (Leqembi) and donanemab (Kisunla), have been approved by the U.S. Food and Drug Administration over the past two years.
NBC264d
FDA approves new Alzheimer's drug to slow disease progression
The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering ...